Compugen (CGEN) Enterprise Value (2009 - 2026)
Compugen recorded quarterly Enterprise Value of -$91.8 million in Q1 2026, up 32.71% quarter-over-quarter from -$136.4 million in Q4 2025.
Compugen's Enterprise Value history runs 12 years deep, the most recent figure standing at -$91.8 million for Q1 2026.
- In Q1 2026, Enterprise Value changed N/A year-over-year to -$91.8 million; the TTM figure through Mar 2026 stood at -$91.8 million (changed N/A YoY), while the FY2025 annual figure was -$136.4 million, down 71.25% from the prior year.
- Enterprise Value came in at -$91.8 million for Q1 2026 at Compugen, up from -$136.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$11.1 million in Q4 2022 to a low of -$136.4 million in Q4 2025.
- A 5-year average of -$68.9 million and a median of -$79.6 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value surged 90.55% in 2022 and plunged 210.65% in 2024, its largest moves.
- Compugen's Enterprise Value stood at -$11.1 million in 2022, then slumped by 131.78% to -$25.6 million in 2023, then slumped by 210.65% to -$79.6 million in 2024, then slumped by 71.25% to -$136.4 million in 2025, then soared by 32.71% to -$91.8 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$91.8 million, -$136.4 million, and -$79.6 million for Q1 2026, Q4 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | -91.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -91.75 Mn |
| Dec 31, 2025 | -99.88 Mn |
| Sep 30, 2025 | -7.46 Mn |
| Jun 30, 2025 | -6.47 Mn |
| Mar 31, 2025 | -14.58 Mn |
| Dec 31, 2024 | -79.63 Mn |
| Sep 30, 2024 | -7.22 Mn |
| Jun 30, 2024 | -11.88 Mn |
| Dec 31, 2023 | -14.26 Mn |
| Jun 30, 2023 | -17.69 Mn |
| Dec 31, 2022 | -11.06 Mn |
| Jun 30, 2022 | -8.73 Mn |
| Dec 31, 2021 | -117.05 Mn |
| Jun 30, 2021 | -8.53 Mn |
| Dec 31, 2020 | -123.77 Mn |
| Jun 30, 2020 | -13.11 Mn |
| Dec 31, 2019 | -9.84 Mn |
| Jun 30, 2019 | -6.86 Mn |
| Dec 31, 2018 | -7.07 Mn |
| Jun 30, 2018 | -11.57 Mn |
| Dec 31, 2017 | -26.52 Mn |
| Jun 30, 2017 | -17.96 Mn |
| Dec 31, 2016 | -10.70 Mn |
| Jun 30, 2016 | -11.77 Mn |
| Dec 31, 2015 | -11.85 Mn |
| Jun 30, 2015 | -26.19 Mn |
| Mar 31, 2015 | -543,000.00 |
| Dec 31, 2014 | -26.19 Mn |
| Jun 30, 2014 | -28.91 Mn |
| Dec 31, 2013 | -28.91 Mn |
| Sep 30, 2013 | -101,000.00 |
| Jun 30, 2013 | -13.19 Mn |
| Mar 31, 2013 | -98,000.00 |
| Dec 31, 2012 | -19.59 Mn |
| Sep 30, 2012 | -91,000.00 |
| Jun 30, 2012 | -8.88 Mn |
| Mar 31, 2012 | -95,000.00 |
| Dec 31, 2011 | -22.37 Mn |
| Sep 30, 2011 | -94,000.00 |
| Jun 30, 2011 | -7.40 Mn |
| Mar 31, 2011 | -99,000.00 |
| Dec 31, 2010 | -21.82 Mn |
| Sep 30, 2010 | -4.43 Mn |
| Jun 30, 2010 | -15.28 Mn |
| Mar 31, 2010 | -152,000.00 |
| Dec 31, 2009 | -15.30 Mn |
| Sep 30, 2009 | -4.65 Mn |
| Jun 30, 2009 | -4.65 Mn |